Ethnicity-specific BRCA1, BRCA2, PALB2, and ATM pathogenic alleles in breast and ovarian cancer patients from the North Caucasus

被引:1
作者
Sokolenko, Anna P. [1 ,2 ]
Bakaeva, Elvina Kh. [1 ]
Venina, Aigul R. [1 ]
Kuligina, Ekaterina Sh. [1 ]
Romanko, Alexandr A. [1 ]
Aleksakhina, Svetlana N. [1 ]
Belysheva, Yana V. [1 ]
Belogubova, Evgeniya V. [1 ]
Stepanov, Ilya A. [1 ]
Zaitseva, Olga A. [1 ]
Yatsuk, Olga S. [1 ]
Togo, Alexandr V. [1 ]
Khamgokov, Zaur M. [3 ]
Kadyrova, Azinat O. [3 ]
Pirmagomedov, Albert Sh. [4 ]
Bolieva, Marina B. [5 ]
Epkhiev, Alexandr A. [5 ]
Tsutsaev, Aslan K. [5 ]
Chakhieva, Madina D. [6 ]
Khabrieva, Khalimat M. [6 ]
Khabriev, Idris M. [6 ]
Murachuev, Mirza A. [7 ]
Buttaeva, Bella N. [8 ]
Baboshkina, Liliya S. [1 ]
Bayramkulova, Fatima I. [9 ]
Katchiev, Islam R. [9 ]
Alieva, Lina Kh. [9 ]
Raskin, Grigory A. [10 ]
Orlov, Sergey V. [11 ]
Khachmamuk, Zarema K. [12 ]
Levonyan, Karine R. [12 ]
Gichko, Dariya M. [13 ]
Kirtbaya, Dmitriy V. [13 ]
Degtyariov, Alexey M. [13 ]
Sultanova, Luisa V. [14 ]
Musayeva, Hedi S. [14 ]
Belyaev, Alexey M. [1 ]
Imyanitov, Evgeny N. [1 ,2 ]
机构
[1] NN Petrov Inst Oncol, Dept Tumor Growth Biol, 68,Pesochny 2, St Petersburg 197758, Russia
[2] St Petersburg Pediat Med Univ, St Petersburg, Russia
[3] Republican Canc Ctr, Nalchik, Russia
[4] City Hosp 1, Nalchik, Russia
[5] Republican Canc Ctr, Vladikavkaz, Russia
[6] Republican Canc Ctr, Pliyevo, Russia
[7] Republican Canc Ctr, Makhachkala, Russia
[8] Republican Bur Pathol, Makhachkala, Russia
[9] Republican Canc Ctr, Cherkessk, Russia
[10] Dr Sergey Berezin Med Inst Biol Syst, St Petersburg, Russia
[11] IP Pavlov St Petersburg State Med Univ, St Petersburg, Russia
[12] Reg Clin Canc Ctr, Krasnodar, Russia
[13] City Canc Ctr, Soci, Russia
[14] Republican Canc Ctr, Grozny, Russia
关键词
BRCA1; BRCA2; Founder effect; Hereditary cancer; North Caucasus; Pathogenic variants; GERMLINE MUTATIONS; HEREDITARY BREAST; RAD51C; GENES; RISK;
D O I
10.1007/s10549-023-07135-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Mountain areas of the North Caucasus host several large ethnic communities that have preserved their national identity over the centuries.Methods This study involved high-grade serous ovarian cancer (HGSOC) and breast cancer (BC) patients from Dagestan (HGSOC: 37; BC: 198), Kabardino-Balkaria (HGSOC: 68; BC: 155), North Ossetia (HGSOC: 51; BC: 104), Chechnya (HGSOC: 68; BC: 79), Ingushetia (HGSOC: 19; BC: 103), Karachay-Cherkessia (HGSOC: 13; BC: 47), and several Armenian settlements (HGSOC: 16; BC: 101). The group of BC patients was enriched by young-onset and/or family history-positive and/or bilateral and/or receptor triple-negative cases. The entire coding region of BRCA1, BRCA2, PALB2, and ATM genes was analyzed by next-generation sequencing.Results A significant contribution of BRCA1/2 pathogenic variants (PVs) to HGSOC and BC development was observed across all North Caucasus regions (HGSOC: 19-39%; BC: 6-13%). Founder alleles were identified in all ethnic groups studied, e.g., BRCA1 c.3629_3630delAG in Chechens, BRCA2 c.6341delC in North Ossetians, BRCA2 c.5351dupA in Ingush, and BRCA1 c.2907_2910delTAAA in Karachays. Some BRCA1/2 alleles, particularly BRCA2 c.9895C > T, were shared by several nationalities. ATM PVs were detected in 14 patients, with c.1673delG and c.8876_8879delACTG alleles occurring twice each. PALB2 heterozygosity was observed in 5 subjects, with one variant seen in 2 unrelated women.Conclusion This study adds to the evidence for the global-wide contribution of BRCA1/2 genes to HGSOC and BC morbidity, although the spectrum of their PVs is a subject of ethnicity-specific variations. The data on founder BRCA1/2 alleles may be considered when adjusting the BRCA1/2 testing procedure to the ethnic origin of patients.
引用
收藏
页码:307 / 315
页数:9
相关论文
共 28 条
[1]   Moderate-Risk Genes for Hereditary Ovarian Cancers Involved in the Homologous Recombination Repair Pathway [J].
Abe, Akiko ;
Imoto, Issei ;
Ueki, Arisa ;
Nomura, Hidetaka ;
Kanao, Hiroyuki .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
[2]  
[Anonymous], 2021, 2021 RUSS CENS
[3]   Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].
Antoniou, A ;
Pharoah, PDP ;
Narod, S ;
Risch, HA ;
Eyfjord, JE ;
Hopper, JL ;
Loman, N ;
Olsson, H ;
Johannsson, O ;
Borg, Å ;
Pasini, B ;
Radice, P ;
Manoukian, S ;
Eccles, DM ;
Tang, N ;
Olah, E ;
Anton-Culver, H ;
Warner, E ;
Lubinski, J ;
Gronwald, J ;
Gorski, B ;
Tulinius, H ;
Thorlacius, S ;
Eerola, H ;
Nevanlinna, H ;
Syrjäkoski, K ;
Kallioniemi, OP ;
Thompson, D ;
Evans, C ;
Peto, J ;
Lalloo, F ;
Evans, DG ;
Easton, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130
[4]  
Antoniou AC, 2014, NEW ENGL J MED, V371, P1651, DOI [10.1056/NEJMoa1400382, 10.1056/NEJMc1410673, 10.1056/NEJMc1410673#SA1]
[5]   Parallel Evolution of Genes and Languages in the Caucasus Region [J].
Balanovsky, Oleg ;
Dibirova, Khadizhat ;
Dybo, Anna ;
Mudrak, Oleg ;
Frolova, Svetlana ;
Pocheshkhova, Elvira ;
Haber, Marc ;
Platt, Daniel ;
Schurr, Theodore ;
Haak, Wolfgang ;
Kuznetsova, Marina ;
Radzhabov, Magomed ;
Balaganskaya, Olga ;
Romanov, Alexey ;
Zakharova, Tatiana ;
Soria Hernanz, David F. ;
Zalloua, Pierre ;
Koshel, Sergey ;
Ruhlen, Merritt ;
Renfrew, Colin ;
Wells, R. Spencer ;
Tyler-Smith, Chris ;
Balanovska, Elena .
MOLECULAR BIOLOGY AND EVOLUTION, 2011, 28 (10) :2905-2920
[6]   Meta-analysis of BRCA1 and BRCA2 penetrance [J].
Chen, Sining ;
Parmigiani, Giovanni .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (11) :1329-1333
[7]   Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers [J].
Golmard, Lisa ;
Castera, Laurent ;
Krieger, Sophie ;
Moncoutier, Virginie ;
Abidallah, Khadija ;
Tenreiro, Henrique ;
Lauge, Anthony ;
Tarabeux, Julien ;
Millot, Gael A. ;
Nicolas, Andre ;
Lae, Marick ;
Abadie, Caroline ;
Berthet, Pascaline ;
Polycarpe, Florence ;
Frebourg, Thierry ;
Elan, Camille ;
de Pauw, Antoine ;
Gauthier-Villars, Marion ;
Buecher, Bruno ;
Stern, Marc-Henri ;
Stoppa-Lyonnet, Dominique ;
Vaur, Dominique ;
Houdayer, Claude .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2017, 25 (12) :1345-1353
[8]  
Imyanitov Evgeny N, 2023, World J Clin Oncol, V14, P40, DOI 10.5306/wjco.v14.i2.40
[9]   The highly prevalent BRCA2 mutation c.2808_2811del (3036delACAA) is located in a mutational hotspot and has multiple origins [J].
Infante, Mar ;
Duran, Mercedes ;
Acedo, Alberto ;
Maria Sanchez-Tapia, Eva ;
Diez-Gomez, Beatriz ;
Barroso, Alicia ;
Garcia-Gonzalez, Maria ;
Feliubadalo, Lidia ;
Lasa, Adriana ;
de la Hoya, Miguel ;
Esteban-Cardenosa, Eva ;
Diez, Orland ;
Martinez-Bouzas, Cristina ;
Godino, Javier ;
Teule, Alexandre ;
Osorio, Ana ;
Lastra, Enrique ;
Gonzalez-Sarmiento, Rogelio ;
Miner, Cristina ;
Velasco, Eladio A. .
CARCINOGENESIS, 2013, 34 (11) :2505-2511
[10]   A spectrum of BRCA1 and BRCA2 germline deleterious variants in ovarian cancer in Russia [J].
Kechin, Andrey ;
Boyarskikh, Ulyana ;
Barinov, Alexey ;
Tanas, Alexander ;
Kazakova, Svetlana ;
Zhevlova, Anastasia ;
Khrapov, Evgeniy ;
Subbotin, Sergey ;
Mishukova, Olga ;
Kekeeva, Tatiana ;
Demidova, Irina ;
Filipenko, Maxim .
BREAST CANCER RESEARCH AND TREATMENT, 2023, 197 (02) :387-395